Get in Touch
Looking to learn more about our innovative system or about AVS? Reach out today.
Contact Information
"*" indicates required fields
Keep Your Finger on the Pulse
Stay up to date on the latest announcements, press releases and more from AVS.
Press Release
AVS Completes a $36M Series B Financing Ahead of IVL U.S. Commercial Launch
BOSTON–(BUSINESS WIRE)–Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease with its novel PULSE IVL™
Read MorePress Release
AVS Enrolls First Patient in U.S. Pivotal Intravascular Lithotripsy Study
BOSTON–(BUSINESS WIRE)–Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease, announced today that it has
Read MorePress Release
AVS Partners with the Jacobs Institute to Expedite Clinical Trials for Coronary and Carotid Indications
BOSTON–(BUSINESS WIRE)–Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease with its Pulse Intravascular Lithotripsy
Read MoreNews
AVS Brings New Approach to Lithotripsy: Vanguards of Health Care
In a Vanguards of Health Care podcast episode, AVS CEO, Mark Toland sits down with BI analyst Matt Henriksson for an in-depth interview to
Read MoreNews
Pulse IVL with Angie Volk & Sean Gilligan of AVS
Angie Volk, VP of Business Development at AVS, and Sean Gilligan, COO at AVS, recently sat down with Kyle Kruse and Richard Meiklejohn on
Read MorePress Release
AVS Receives IDE Approval from FDA for Pivotal Intravascular Lithotripsy Study
BOSTON–(BUSINESS WIRE)–Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease, announced today that it has
Read MorePress Release
AVS Appoints Elizabeth Galle as Vice President of Clinical Affairs
BOSTON–(BUSINESS WIRE)–AVS (Amplitude Vascular Systems, Inc), an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVL™
Read MoreNews
Cardio Conversations: AVS Talks about Starting a Company in a Pandemic, Cracking Peripheral Plaques and More
Robert Chisena, Ph.D., our CTO and Co-Founder, recently chatted with Reed Miller on the latest edition of the Cardio Conversations, a MedTech Insight podcast, to share his thoughts on our interventional technology,
Read MoreNews
AVS’ PIVL™ System in growing PAD market; Details on Medtech’s new digital playbook
AVS Chief Operating Officer, Sean Gilligan, recently sat down with Tom Salemi on the DeviceTalks podcast to discuss AVS’ approach to intravascular lithotripsy and the
Read MorePress Release
AVS Opens Global Headquarters in Boston’s Seaport District to Support Growth
BOSTON–(BUSINESS WIRE)–AVS (Amplitude Vascular Systems, Inc), an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVL™
Read More